First-line treatment with pulsed field ablation (PFA) reduced the risk of recurrence of atrial arrhythmia among patients with persistent atrial fibrillation (Afib), the randomized AVANT GUARD trial ...
There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...
Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...
Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation ...
Electrophysiology procedures take place in hospitals. That’s been the widely held assumption — until now. There’s plenty of reasons that people think EP procedures belong in hospitals. After all, in ...
London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...
Please provide your email address to receive an email when new articles are posted on . An all-in-one ablation system showed durable pulmonary vein isolation at 1 year. Three-quarters of patients ...
The recent findings revealed no statistically significant difference in 3-year disease-free survival (DFS) between women who underwent microwave ablation and women who underwent conventional ...
Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...
Mayo Clinic's Engineering and Therapeutics in Gastrointestinal Disease Lab is developing novel gastric remodeling to improve obesity and obesity-related metabolic conditions.
If you are diagnosed with early-stage prostate cancer, you usually have three treatment choices: monitoring (called active surveillance), surgery, or radiation therapy. Whole-gland ablation is an ...
The absolute difference in cancer-specific survival for thermal ablation vs surgery for T1a RCC was just 1%. Cancer-specific survival among patients with stage T1a renal cell carcinoma (RCC) is ...